Have a personal or library account? Click to login
Indole-3-propionic acid reduces lipid peroxidation induced by potassium iodate in porcine thyroid Cover

Indole-3-propionic acid reduces lipid peroxidation induced by potassium iodate in porcine thyroid

Open Access
|Feb 2025

References

  1. Abildgaard A, Elfving B, Hokland M, Wegener G, Lund S. (2018). The microbial metabolite indole-3 propionic acid improves glucose metabolism in rats, but does not affect behaviour. Arch Physiol Biochem 124: 306–312.
  2. Ates I, Yilmaz FM, Altay M, Yilmaz N, Berker D, Güler S. (2015). The relationship between oxidative stress and autoimmunity in Hashimoto’s thyroiditis. Eur J Endocrinol 173: 791–799.
  3. Bendheim PE, Poeggeler B, Neria E, Ziv V, Pappolla MA, Chain DG. (2002). Development of indole-3-propionic acid (OXIGON) for Alzheimer’s disease. J Mol Neurosci 19: 213–217.Review.
  4. Blankenship JL, Garrett GS, Khan NA, De-Regil LM, Spohrer R, Gorstein J. (2018). Effect of iodized salt on organoleptic properties of processed foods: a systematic review. J Food Sci Technol 55: 3341–3352.
  5. Bouga M, Lean MEJ, Combet E. (2018). Contemporary challenges to iodine status and nutrition: the role of foods, dietary recommendations, fortification and supplementation. Proc Nutr Soc 77: 302–313.
  6. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
  7. Brieger K, Schiavone S, Miller FJ Jr, Krause K-H. (2012). Reactive oxygen species: from health to disease. Swiss Med Wkly 17: 142: w13659.
  8. Bürgi H, Schaffner T, Seiler JP. (2001). The Toxicology of Iodate: A Review of the Literature. Thyroid 11: 449–456.
  9. Cao X, Ma W, Liu L, Xu J, Wang H, Li X, Wang J, Zhang J, Wang Z, Gu Y. (2015). Analysis of potassium iodate reduction in tissue homogenates using high performance liquid chromatography-inductively coupled plasma-mass spectrometry. J Trace Elem Med Biol 32: 1–6.
  10. Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, Pappolla MA. (1999). Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 274: 21937–21942.
  11. Harderland R, Zsizsik BK, Poeggeler B, Fuhrberg B, Holst S, Coto-Montes A. (1999). Indole-3-pyruvic and -propionic acids, kynurenic acid, and related metabolites as luminophores and free-radical scavengers. Adv Exp Med Biol 467: 389–395.
  12. Iodine Global Network [webpage on the Internet] [cited 06.04.2020] Available from: www.ign.org.
  13. Iwan P, Stepniak J, Karbownik-Lewinska M. (2021). Melatonin reduces high levels of lipid peroxidation induced by potassium iodate in porcine thyroid. Int J Vitam Nutr Res 91: 271–277.
  14. Karbownik M, Stasiak M, Zasada K, Zygmunt A, Lewinski A. (2005). Comparison of potential protective effects of melatonin, indole-3-propionic acid, and propylthiouracil against lipid peroxidation caused by potassium bro-mate in the thyroid gland. J Cell Biochem 95: 131–138.
  15. Karbownik-Lewinska M, Stepniak J, Milczarek M, Lewinski A. (2015). Protective effect of KI in mtDNA in porcine thyroid: comparison with KIO3 and nDNA. Eur J Nutr 54: 319–323.
  16. Karbownik-Lewinska M and Kokoszko-Bilska A. (2012). Oxidative damage to macromolecules in the thyroid – experimental evidence. Thyroid Res 5: 25.
  17. Kehrer JP and Klotz LO. (2015). Free radicals and related reactive species as mediators of tissue injury and disease: implications for health. Crit Rev Toxicol 45: 765–798.
  18. Konopelski P, Konop M, Gawrys-Kopczynska M, Podsadni P, Szczepanska A, Ufnal M. (2019). Indole-3-propionic acid, a tryptophan-derived bacterial metabolite, reduces weight gain in rats. Nutrients 11: 591.
  19. Milczarek M, Stepniak J, Lewinski A, Karbownik-Lewińska M. (2013). Potassium iodide, but not potassium iodate, as a potential protective agent against oxidative damage to membrane lipids in porcine thyroid. Thyroid Res 6: 10.
  20. Nicola JP, Carrasco N, Masini-Repiso AM. (2015). Dietetary I- Absorption: Expression and Regulation of the Na+/I− Symporter in the Intestine. Vitam Horm 98: 1–31.
  21. Niwattisaiwong S, Burman KD, Li-Ng M. (2017). Iodine deficiency: Clinical implications. Cleve Clin J Med 84: 236–244.
  22. Poeggeler B, Pappolla MA, Hardeland R, Rassoulpour A, Hodgkins PS, Guidetti P, Schwarcz R. (1999). Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain. Brain Res 815: 382–388.
  23. Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L. (2016). Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61: 253–278.
  24. Tabur S, Aksoy ŞN, Korkmaz H, Ozkaya M, Aksoy N, Akarsu E. (2015). Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumour Biol 36: 2667–2674.
  25. Taurog A, Chaikoff IL, Feller DD. (1947). The mechanism of iodine concentration by the thyroid gland: its non-organic iodine-binding capacity in the normal and propylthiouracil-treated rat. J Biol Chem 171: 189–201.
  26. Taurog A, Tong W, Chaikoff IL. (1951). Non-thyroglobulin iodine of the thyroid gland II. Inorganic iodide. J Biol Chem 191: 677–682.
  27. Tiran B, Karpf E, Tiran A, Lax S, Langsteger W, Eber O, Lorenz O. (1993). Iodine content of thyroid tissue in the Styrian population. Acta Med Austriaca 20: 6–8.
  28. Trumbo PR. (2016). FDA regulations regarding iodine addition to foods and labeling of foods containing added iodine. Am J Clin Nutr 104 (Suppl 3): 864S–867S.
  29. Wu T, Liu GJ, Li P, Clar C. (2002). Iodised salt for preventing iodine deficiency disorders. Cochrane Database Syst Rev (3): CD003204.
  30. Zhao ZH, Xin FZ, Xue Y, Hu Z, Han Y, Ma F, Zhou D, Liu X, Cui A, Liu Z, Liu Y, Gao J, Pan Q, Li Y, Fan J. (2019). Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Exp Mol Med 51: 1–14.
DOI: https://doi.org/10.2478/intox-2021-0007 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 47 - 51
Submitted on: Aug 31, 2020
Accepted on: Dec 6, 2020
Published on: Feb 17, 2025
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Paulina Iwan, Malgorzata Karbownik-Lewinska, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.